It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Orthogeriatrics is increasingly recommended in the care of hip fracture patients, although evidence for this model is conflicting or at least limited. Furthermore, there is no conclusive evidence on which model [geriatric medicine consultant service (GCS), geriatric medical ward with orthopedic surgeon consultant service (GW), integrated care model (ICM)] is superior. The review summarizes the effect of orthogeriatric care for hip fracture patients on length of stay (LOS), time to surgery (TTS), in-hospital mortality, 1-year mortality, 30-day readmission rate, functional outcome, complication rate, and cost. Two independent reviewers retrieved randomized controlled trials, controlled observational studies, and pre/post analyses. Random-effects meta-analysis was performed. Thirty-seven studies were included, totaling 37.294 patients. Orthogeriatric care significantly reduced LOS [mean difference (MD) − 1.55 days, 95% confidence interval (CI) (− 2.53; − 0.57)], but heterogeneity warrants caution in interpreting this finding. Orthogeriatrics also resulted in a 28% lower risk of in-hospital mortality [95%CI (0.56; 0.92)], a 14% lower risk of 1-year mortality [95%CI (0.76; 0.97)], and a 19% lower risk of delirium [95%CI (0.71; 0.92)]. No significant effect was observed on TTS and 30-day readmission rate. No consistent effect was found on functional outcome. Numerically lower numbers of complications were observed in orthogeriatric care, yet some complications occurred more frequently in GW and ICM. Limited data suggest orthogeriatrics is cost-effective. There is moderate quality evidence that orthogeriatrics reduces LOS, in-hospital mortality, 1-year mortality, and delirium of hip fracture patients and may reduce complications and cost, while the effect on functional outcome is inconsistent. There is currently insufficient evidence to recommend one or the other type of orthogeriatric care model.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 KU Leuven, Faculty of Medicine, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)
2 UCLouvain, Institute of Statistics, Biostatistics and Actuarial Sciences, Louvain-la-Neuve, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X)
3 KU Leuven, Gerontology and Geriatrics, Department of Public Health and Primary Care, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884); UZ Leuven, Centre for Metabolic Bone Diseases, Leuven, Belgium (GRID:grid.410569.f) (ISNI:0000 0004 0626 3338); University Hospitals Leuven, Department of Geriatrics, Leuven, Belgium (GRID:grid.410569.f) (ISNI:0000 0004 0626 3338)
4 UZ Leuven, Centre for Metabolic Bone Diseases, Leuven, Belgium (GRID:grid.410569.f) (ISNI:0000 0004 0626 3338); Imelda Hospital, Geriatrics Department, Bonheiden, Belgium (GRID:grid.414579.a) (ISNI:0000 0004 0608 8744)